Insulin detemir Subcutaneous and Panitumumab Intravenous
Determining the interaction of Insulin detemir Subcutaneous and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin detemir
Brand name: Levemir, Levemir FlexPen, Levemir PenFill, Levemir InnoLet, Levemir FlexTouch
Synonyms: Insulin detemir, Insulin Detemir
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin detemir Subcutaneous-Panixine
- Insulin detemir Subcutaneous-Panixine DisperDose
- Insulin detemir Subcutaneous-Panlor
- Insulin detemir Subcutaneous-Panlor Tablet
- Insulin detemir Subcutaneous-Panlor Tablets
- Insulin detemir Subcutaneous-Panlor-DC
- Panitumumab Intravenous-Insulin glargine
- Panitumumab Intravenous-Insulin Glargine (U-100) Cartridge Systems and Pens
- Panitumumab Intravenous-Insulin Glargine (U-100) Vials
- Panitumumab Intravenous-Insulin Glargine (U-300) Pens
- Panitumumab Intravenous-Insulin glargine and lixisenatide
- Panitumumab Intravenous-Insulin glargine and lixisenatide Subcutaneous